Cargando…

Survival benefits of antiretroviral therapy in Brazil: a model-based analysis

OBJECTIVE: In Brazil, universal provision of antiretroviral therapy (ART) has been guaranteed free of charge to eligible HIV-positive patients since December 1996. We sought to quantify the survival benefits of ART attributable to this programme. METHODS: We used a previously published microsimulati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luz, Paula M, Girouard, Michael P, Grinsztejn, Beatriz, Freedberg, Kenneth A, Veloso, Valdilea G, Losina, Elena, Struchiner, Claudio J, MacLean, Rachel L, Parker, Robert A, Paltiel, A David, Walensky, Rochelle P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814587/ https://www.ncbi.nlm.nih.gov/pubmed/27029828 http://dx.doi.org/10.7448/IAS.19.1.20623

Ejemplares similares

Cost-Effectiveness of Genotype Testing for Primary Resistance in Brazil
por: Luz, Paula M., et al.
Publicado: (2015)

The cost‐effectiveness of HIV pre‐exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil
por: Luz, Paula M, et al.
Publicado: (2018)

Effectiveness of first-line antiretroviral therapy in the IPEC cohort, Rio de Janeiro, Brazil
por: Cardoso, Sandra W, et al.
Publicado: (2014)

The Survival Benefits of Antiretroviral Therapy in South Africa
por: April, Michael D., et al.
Publicado: (2014)

Late initiation of antiretroviral therapy: inequalities by educational level despite universal access to care and treatment
por: Rodrigues, Amanda, et al.
Publicado: (2021)

Correction to: Late initiation of antiretroviral therapy: inequalities by educational level despite universal access to care and treatment
por: Rodrigues, Amanda, et al.
Publicado: (2021)

Long-Term CD4+ Cell Count in Response to Combination Antiretroviral Therapy
por: Luz, Paula M., et al.
Publicado: (2014)

Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India
por: Freedberg, Kenneth A., et al.
Publicado: (2018)

Towards an ideal antiretroviral regimen for the global HIV epidemic
por: Grinsztejn, Beatriz, et al.
Publicado: (2017)

Impact of pre-exposure prophylaxis uptake among gay, bisexual, and other men who have sex with men in urban centers in Brazil: a modeling study
por: Luz, Paula M., et al.
Publicado: (2023)

Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d’Ivoire: A model-based analysis
por: Ouattara, Eric N., et al.
Publicado: (2019)

HIV Cure Strategies: How Good Must They Be to Improve on Current Antiretroviral Therapy?
por: Sax, Paul E., et al.
Publicado: (2014)

Pharmacy refill data can be used to predict virologic failure for patients on antiretroviral therapy in Brazil
por: Martin, David, et al.
Publicado: (2017)

Pre-exposure prophylaxis for men and transgender women who have sex with men in Brazil: opportunities and challenges
por: Veloso, Valdilea G, et al.
Publicado: (2015)

Drug-Resistant Tuberculosis among HIV-Infected Patients Starting Antiretroviral Therapy in Durban, South Africa
por: Hom, Jeffrey K., et al.
Publicado: (2012)

Prenatal Transmission of Syphilis and Human Immunodeficiency Virus in Brazil: Achieving Regional Targets for Elimination
por: Cerda, Rodrigo, et al.
Publicado: (2015)

Predictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil
por: Coelho, Lara E., et al.
Publicado: (2016)

COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil
por: Castro, Rodolfo, et al.
Publicado: (2020)

Hospitalization rates, length of stay and in-hospital mortality in a cohort of HIV infected patients from Rio de Janeiro, Brazil
por: Coelho, Lara E., et al.
Publicado: (2016)

Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil
por: Cardoso, Sandra W, et al.
Publicado: (2014)

The HIV epidemic in Latin America: accomplishments and challenges on treatment and prevention
por: Luz, Paula M., et al.
Publicado: (2019)

Cost-Effectiveness of Preventing Loss to Follow-up in HIV Treatment Programs: A Côte d'Ivoire Appraisal
por: Losina, Elena, et al.
Publicado: (2009)

A call to improve understanding of Undetectable equals Untransmittable (U = U) in Brazil: a web‐based survey
por: Torres, Thiago S, et al.
Publicado: (2020)

SARS-CoV-2 testing disparities across geographical regions from a large metropolitan area in Brazil: Results from a web-based survey among individuals interested in clinical trials for COVID-19 vaccines
por: Torres, Thiago S., et al.
Publicado: (2021)

Incidence rate of modifying or discontinuing first combined antiretroviral therapy regimen due to toxicity during the first year of treatment stratified by age
por: Torres, Thiago Silva, et al.
Publicado: (2013)

Vitamin D(3) supplementation in HIV infection: effectiveness and associations with antiretroviral therapy
por: Coelho, Lara, et al.
Publicado: (2015)

Trends in overall opportunistic illnesses, Pneumocystis carinii pneumonia, cerebral toxoplasmosis and Mycobacterium avium complex incidence rates over the 30 years of the HIV epidemic: a systematic review
por: Coelho, Lara, et al.
Publicado: (2013)

Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States
por: Paltiel, A. David, et al.
Publicado: (2020)

COVID-19 screening strategies that permit the safe re-opening of college campuses
por: Paltiel, A. David, et al.
Publicado: (2020)

Obesity Following Antiretroviral Therapy (ART) Initiation is Common and Influenced by Both Traditional and HIV-/ART-Specific Risk Factors
por: Bakal, David, et al.
Publicado: (2017)

Absence of Effect of Menopause Status at Initiation of First-Line Antiretroviral Therapy on Immunologic or Virologic Responses: A Cohort Study from Rio de Janeiro, Brazil
por: Calvet, Guilherme Amaral, et al.
Publicado: (2014)

Mobile HIV Screening in Cape Town, South Africa: Clinical Impact, Cost and Cost-Effectiveness
por: Bassett, Ingrid V., et al.
Publicado: (2014)

Early mortality in a cohort of people living with HIV in Rio de Janeiro, Brazil, 2004–2015: a persisting problem
por: Leite, Pedro H. A. C., et al.
Publicado: (2022)

Factors Associated with Tobacco Smoking and Cessation among HIV-Infected Individuals under Care in Rio de Janeiro, Brazil
por: Torres, Thiago S., et al.
Publicado: (2014)

Age-standardized mortality rates related to viral hepatitis in Brazil
por: Perazzo, Hugo, et al.
Publicado: (2017)

Using national laboratory data to assess cumulative frequency of linkage after transfer to community‐based HIV clinics in South Africa
por: Bassett, Ingrid V, et al.
Publicado: (2019)

Transmitted drug resistance in patients with acute/recent HIV infection in Brazil
por: Ferreira, Ana Cristina G., et al.
Publicado: (2017)

The cost‐effectiveness and budgetary impact of a dolutegravir‐based regimen as first‐line treatment of HIV infection in India
por: Zheng, Amy, et al.
Publicado: (2018)

Trends and predictors of non‐communicable disease multimorbidity among adults living with HIV and receiving antiretroviral therapy in Brazil
por: Castilho, Jessica L, et al.
Publicado: (2019)

Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection
por: Walensky, Rochelle P., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v9331cvg6ua9hvjb48fid28np0